Citations

Showing 10 of 108081 citations.

A Single-Center Bleeding Comparison of Warfarin Plus Aspirin or Clopidogrel Following Coronary Artery Bypass Grafting and Surgical Valve Replacement
Zieminski, Joseph J , Mara, Kristin C. , Wamsley, Kyle S., Stulak, John M., Nei, Scott D. , Mara, Kristin C

Mayo Clinic

Clinical and Applied Thrombosis/Hemostasis | March 28, 2023 | Volume: 29 | Issue: No issue available | Pages: No page available

10.1177/10760296231156175 | PMID 36974469 Get It

The optimal antithrombotic therapy following combined coronary artery bypass graft (CABG) and surgical valve replacement (SVR) surgery remains unclear. The aim of this single-center, retrospective cohort study was to assess the safety and effectiveness of a vitamin K antagonist (VKA) plus either aspirin or clopidogrel in patients following combined CABG and SVR. The primary endpoint was the occurrence of bleeding within six months. The secondary endpoint was the occurrence of CV death, stroke, acute coronary syndrome (ACS), or valve dysfunction. Outcomes were identified by pre-specified ICD codes. A total of 629 patients were included in the analysis, with 583 patients receiving aspirin and 46 patients receiving clopidogrel. Bleeding occurred in 1.7% of patients receiving aspirin and in 0% of patients receiving clopidogrel (p = 0.99). CV death, stroke, ACS, or valve dysfunction occurred in 3.1% of patients receiving aspirin and 4.3% of patients receiving clopidogrel (p = 0.65). In this study, there were no differences in the safety or effectiveness of a VKA plus either aspirin or clopidogrel following combined CABG and SVR.
Assessing collaborative efforts of making care fit for each patient: A systematic review
Kunneman, Marleen , Gravholt, Derek, Hartasanchez, Sandra A. , Paskins, Zoé , Montori, Víctor M. , Montori, Victor M , Gravholt, Derek L. , Gionfriddo, Michael R. , Prokop, Larry J. , Stiggelbout, Anne M.

Mayo Clinic

Health Expectations | March 28, 2023 | Volume: 26 | Issue: 4 | Pages: 1391-1403

10.1111/hex.13759 | PMID 36973176 Get It

AbstractIntroductionFor too many people, their care plans are designed without fully accounting for who they are, the lives they live, what matters to them or what they aspire to achieve. We aimed to summarize instruments capable of measuring dimensions of patient–clinician collaboration to make care fit.MethodsWe systematically searched several databases (Medline, Embase, Cochrane, Scopus and Web of Science) from inception to September 2021 for studies using quantitative measures to assess, evaluate or rate the work of making care fit by any participant in real‐life clinical encounters. Eligibility was assessed in duplicate. After extracting all items from relevant instruments, we coded them deductively on dimensions relevant to making care fit (as presented in a recent Making Care Fit Manifesto), and inductively on the main action described.ResultsWe included 189 papers, mostly from North America (N = 83, 44%) and in the context of primary care (N = 54, 29%). Half of the papers (N = 88, 47%) were published in the last 5 years. We found 1243 relevant items to assess efforts of making care fit, included within 151 instruments. Most items related to the dimensions ‘Patient‐clinician collaboration: content’ (N = 396, 32%) and ‘Patient‐clinician collaboration: manner’ (N = 382, 31%) and the least related to ‘Ongoing and iterative process’ (N = 22, 2%) and in ‘Minimally disruptive of patient lives’ (N = 29, 2%). The items referred to 27 specific actions. Most items referred to ‘Informing’ (N = 308, 25%) and ‘Exploring’ (N = 93, 8%), the fewest items referred to ‘Following up’, ‘Comforting’ and ‘Praising’ (each N = 3, 0.2%).DiscussionMeasures of the work that patients and clinicians do together to make care fit focus heavily on the content of their collaborations, particularly on exchanging information. Other dimensions and actions previously identified as crucial to making care fit are assessed infrequently or not at all. The breadth of extant measures of making care fit and the lack of appropriate measures of this key construct limit both the assessment and the successful implementation of efforts to improve patient care.Patient ContributionPatients and caregivers from the ‘Making care fit Collaborative’ were involved in drafting the dimensions relevant to patient–clinician collaboration.
Distinct Phenotypes of Non-Citizen Kidney Transplant Recipients in the United States by Machine Learning Consensus Clustering
Vaitla, Pradeep , Leeaphorn, Napat , Mao, Michael A. , Qureshi, Fahad , Kaewput, Wisit , Tangpanithandee, Supawit , Pattharanitima, Pattharawin , Acharya, Prakrati , Cheungpasitporn, Wisit , Jadlowiec, Caroline , Mao, Michael A , Qureshi, Fahad , Kaewput, Wisit , Tangpanithandee, Supawit , Krisanapan, Pajaree , Pattharanitima, Pattharawin , Nissaisorakarn, Pitchaphon , Cheungpasitporn, Wisit , Thongprayoon, Charat , Jadlowiec, Caroline C. , Mao, Shennen A. , Qureshi, Fawad , Krisanapan, Pajaree , Nissaisorakarn, Pitchaphon , Cooper, Matthew

Mayo Clinic

Medicines | March 28, 2023 | Volume: 10 | Issue: 4 | Pages: 25

10.3390/medicines10040025 | PMID 37103780 Get It

Background: Better understanding of the different phenotypes/subgroups of non-U.S. citizen kidney transplant recipients may help the transplant community to identify strategies that improve outcomes among non-U.S. citizen kidney transplant recipients. This study aimed to cluster non-U.S. citizen kidney transplant recipients using an unsupervised machine learning approach; Methods: We conducted a consensus cluster analysis based on recipient-, donor-, and transplant- related characteristics in non-U.S. citizen kidney transplant recipients in the United States from 2010 to 2019 in the OPTN/UNOS database using recipient, donor, and transplant-related characteristics. Each cluster’s key characteristics were identified using the standardized mean difference. Post-transplant outcomes were compared among the clusters; Results: Consensus cluster analysis was performed in 11,300 non-U.S. citizen kidney transplant recipients and identified two distinct clusters best representing clinical characteristics. Cluster 1 patients were notable for young age, preemptive kidney transplant or dialysis duration of less than 1 year, working income, private insurance, non-hypertensive donors, and Hispanic living donors with a low number of HLA mismatch. In contrast, cluster 2 patients were characterized by non-ECD deceased donors with KDPI <85%. Consequently, cluster 1 patients had reduced cold ischemia time, lower proportion of machine-perfused kidneys, and lower incidence of delayed graft function after kidney transplant. Cluster 2 had higher 5-year death-censored graft failure (5.2% vs. 9.8%; p < 0.001), patient death (3.4% vs. 11.4%; p < 0.001), but similar one-year acute rejection (4.7% vs. 4.9%; p = 0.63), compared to cluster 1; Conclusions: Machine learning clustering approach successfully identified two clusters among non-U.S. citizen kidney transplant recipients with distinct phenotypes that were associated with different outcomes, including allograft loss and patient survival. These findings underscore the need for individualized care for non-U.S. citizen kidney transplant recipients.
Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
Chahine, Lana M. , Beach, Thomas G. , Hepker, Monica, Kanthasamy, Anumantha G. , Appel, Scott, Pritzkow, Sandra , Pinho, Michelle, Mosovsky, Sherri, Coffey, Christopher S. , Oliveira, Luís M. A. , Eberling, Jamie L., Mollenhauer, Brit , Study, For the Systemic Synuclein Sampling, Amara, Amy W. , Kanthasamy, Anumantha , Visanji, Naomi P , Adler, Charles H. , Serrano, Geidy E. , Brumm, Michael C. , Study, For the Systemic Synuclein Sampling

Mayo Clinic

Annals of Clinical and Translational Neurology | March 28, 2023 | Volume: 10 | Issue: 5 | Pages: 696-705

10.1002/acn3.51753 | PMID 36972727 Get It

AbstractObjectivesDetection of α‐synuclein aggregates by seed amplification is a promising Parkinson disease biomarker assay. Understanding intraindividual relationships of α‐synuclein measures could inform optimal biomarker development. The objectives were to test accuracy of α‐synuclein seed amplification assay in central (cerebrospinal fluid) and peripheral (submandibular gland) sources, compare to total α‐synuclein measures, and investigate within‐subject relationships.MethodsThe Systemic Synuclein Sampling Study aimed to characterize α‐synuclein in multiple tissues and biofluids within Parkinson disease subjects (n = 59) and compared to healthy controls (n = 21). Motor and non‐motor measures and dopamine transporter scans were obtained. Four measures of α‐synuclein were compared: seed amplification assay in cerebrospinal fluid and formalin‐fixed paraffin‐embedded submandibular gland, total α‐synuclein quantified in biofluids using enzyme‐linked immunoassay, and aggregated α‐synuclein in submandibular gland detected by immunohistochemistry. Accuracy of seed amplification assay for Parkinson disease diagnosis was examined and within‐subject α‐synuclein measures were compared.ResultsSensitivity and specificity of α‐synuclein seed amplification assay for Parkinson disease diagnosis was 92.6% and 90.5% in cerebrospinal fluid, and 73.2% and 78.6% in submandibular gland, respectively. 25/38 (65.8%) Parkinson disease participants were positive for both cerebrospinal fluid and submandibular gland seed amplification assay. Comparing accuracy for Parkinson disease diagnosis of different α‐synuclein measures, cerebrospinal fluid seed amplification assay was the highest (Youden Index = 83.1%). 98.3% of all Parkinson disease cases had ≥1 measure of α‐synuclein positive.Interpretationα‐synuclein seed amplification assay (cerebrospinal fluid>submandibular gland) had higher sensitivity and specificity compared to total α‐synuclein measures, and within‐subject relationships of central and peripheral α‐synuclein measures emerged.
7T MRI in transient ischemic attacks: Have we only seen the tip of the iceberg?
Lakhani, Dhairya A. , Zhou, Xiangzhi , Tao, Shengzhen , Westerhold, Erin , Eidelman, Benjamin H., Middlebrooks, Erik H. , Westerhold, Erin M, Vibhute, Prasanna , Singh Sandhu, Sukhwinder Johnny, Middlebrooks, Erik H , Lakhani, Dhairya , Sandhu, Sukhwinder J.S.

Mayo Clinic

The Neuroradiology Journal | March 27, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/19714009231166089 | PMID 36973640 Get It

Transient ischemic attack (TIA) has gained significant attention recently due to the increased incidence of subsequent stroke. However, there are many nonvascular clinical mimics of TIA, creating a need for improved biomarkers to identify a vascular origin. Following the recent approval of ultra-high field (UHF) 7T MRI in clinical practice, several clinical studies have highlighted its added utility in neuroimaging compared to lower-field 1.5T and 3T MRI, particularly in epilepsy and multiple sclerosis. Our case series of three patients with TIA illustrates that 7T MRI can depict small areas of intracortical microhemorrhages and microinfarctions, which could not be resolved with 3T or 1.5T MRI. There are currently no reports of intracortical localization of microhemorrhages in patients with TIA. This discovery may enhance our understanding and characterization of cerebrovascular abnormalities in TIAs. In addition, UHF imaging could potentially be utilized to distinguish transient neurological episodes secondary to cerebrovascular events from other differential considerations. Our cases highlight the underestimation of imaging abnormalities in cases of TIA and support the potential expanded application of clinical 7T to assess patients with TIA. Future studies are necessary at 7T redundant to determine the true incidence of such lesions in TIA and to examine the correlation between cortical microhemorrhages and subsequent ischemic stroke, hemorrhagic events, and neurocognitive impairment.
Bibliometric Analysis of the Top 100 Cited Articles on Stereotactic Radiosurgery for Trigeminal Neuralgia
Parikh, Parth , Abdallah, Hussein , Patel, Aneek , Shariff, Rimsha K., Mallela, Arka N. , Sekula, Raymond F. , Lunsford, L. Dade , Abou‐Al‐Shaar, Hussam , Abdallah, Hussein M , Mallela, Arka N , Nowicki, Kamil W. , Tonetti, Daniel A.

Mayo Clinic

Asian Journal of Neurosurgery | March 27, 2023 | Volume: 18 | Issue: 01 | Pages: 101-107

10.1055/s-0043-1761240 | PMID 37056872 Get It

Abstract Background Stereotactic radiosurgical rhizolysis of the trigeminal nerve is an established modality increasingly employed to alleviate the symptoms of refractory trigeminal neuralgia. This study analyzes the academic impact of the top 100 cited articles on the radiosurgical management of trigeminal neuralgia. Methods The Scopus database was searched for articles containing “radiosurgery” and one or more of “trigeminal neuralgia,” “trigeminus neuralgia,” and “tic douloureux.” The top 100 articles written in English were arranged in descending order by citation count. Documents were evaluated for authors, publication year, journal and impact factor, total citations, nationality, study type, radiosurgical modality, and the affiliated institution. Quantitative and qualitative analyses were performed on the data. Results The most cited articles were published between 1971 and 2019. The average citation per year was 4.3. The most targeted anatomic area was the “root entry zone” or proximal portion of the cisternal segment of the trigeminal nerve. The most utilized modality was Gamma Knife radiosurgery. The country with the highest number of publications was the United States. Thirty-six percent of the articles were published in the Journal of Neurosurgery. Lunsford, Kondziolka, Flickinger, and Régis, respectively, were the most frequently listed co-authors. The most prolific institute was the University of Pittsburgh Medical Center. Conclusion Stereotactic radiosurgery is an important modality in the management of medically or surgically refractory trigeminal neuralgia. This analysis assesses its contributions over the past five decades to identify trends in treatment practices for neurosurgeons and to highlight areas where further study is needed.
Acute on chronic liver failure: prognostic models and artificial intelligence applications
Gary, Phillip , Lal, Amos , Gajic, Ognjen , Moraes, Alice Gallo de , Gary, Phillip J , Simonetto, Douglas A , Gajic, Ognjen , Gallo de Moraes, Alice , Lal, Amos , Simonetto, Douglas A.

Mayo Clinic

Hepatology Communications | March 27, 2023 | Volume: 7 | Issue: 4 | Pages: No page available

10.1097/hc9.0000000000000095 | PMID 36972378 Get It

Critically ill patients presenting with acute on chronic liver failure (ACLF) represent a particularly vulnerable population due to various considerations surrounding the syndrome definition, lack of robust prospective evaluation of outcomes, and allocation of resources such as organs for transplantation. Ninety-day mortality related to ACLF is high and patients who do leave the hospital are frequently readmitted. Artificial intelligence (AI), which encompasses various classical and modern machine learning techniques, natural language processing, and other methods of predictive, prognostic, probabilistic, and simulation modeling, has emerged as an effective tool in various areas of healthcare. These methods are now being leveraged to potentially minimize physician and provider cognitive load and impact both short-term and long-term patient outcomes. However, the enthusiasm is tempered by ethical considerations and a current lack of proven benefits. In addition to prognostic applications, AI models can likely help improve the understanding of various mechanisms of morbidity and mortality in ACLF. Their overall impact on patient-centered outcomes and countless other aspects of patient care remains unclear. In this review, we discuss various AI approaches being utilized in healthcare and discuss the recent and expected future impact of AI on patients with ACLF through prognostic modeling and AI-based approaches.
Letter to the Editor Concerning “Does Erector Spinae Plane Block Decrease Analgesia Requirements after Minimal-Invasive Posterior Transpedicular Stabilization in Patients with Vertebral Body Fracture?”
Gadjradj, Pravesh S. , Cofano, Sean, Sommer, Fabian , Navarro-Ramírez, Rodrigo , Rooij, Judith D. de, Bielecki, Mateusz

Mayo Clinic

Global Spine Journal | March 27, 2023 | Volume: 14 | Issue: 3 | Pages: 1093-1094

10.1177/21925682231166903 | PMID 36972677 Get It

The effect of common dental fixtures on treatment planning and delivery for head and neck intensity modulated proton therapy
Hu, Yue‐Houng , Seum, Wan Chan Tseung Hok, Muller, Olivia M. , Foote, Robert L. , Mundy, Daniel W. , Hunzeker, Ashley, Muller, Olivia, Hunzeker, Ashley E.

Mayo Clinic

Journal of Applied Clinical Medical Physics | March 27, 2023 | Volume: 24 | Issue: 7 | Pages: No page available

10.1002/acm2.13973 | PMID 36972299 Get It

AbstractPurposeProton treatment plan perturbation by common dental fixtures such as amalgams (Am) and porcelain‐fused‐to‐metal (PFM) crowns has, to date, been uncharacterized. Previous studies have been conducted to determine the physical effect of these materials within the beam path for single spots, but their effects on complex treatment plans and clinical anatomy have not yet been quantified. The present manuscript aims to study the effect of Am and PFM fixtures on proton treatment planning in a clinical setting.MethodsAn anthropomorphic phantom with removable tongue, maxilla, and mandible modules was simulated on a clinical computed tomography (CT) scanner. Spare maxilla modules were modified to include either a 1.5 mm depth central groove occlusal amalgam (Am) or a porcelain‐fused‐to‐metal (PFM) crown, implanted on the first right molar. Modified tongue modules were 3D printed to accommodate several axial or sagittal oriented pieces of EBT‐3 film. Clinically representative spot‐scanning proton plans were generated in Eclipse v.15.6 using the proton convolution superposition (PCS) algorithm v.15.6.06 using a multi‐field optimization (MFO) technique with the goal of delivering a uniform 54 Gy dose to a clinical target volume (CTV) typical of a base‐of‐tongue (BoT) treatment. A typical geometric beam arrangement of two anterior oblique (AO) beams and a posterior beam was employed. Plans optimized without any material overrides were delivered to the phantom A) without implants; B) with Am fixture; or C) with PFM crown. Plans were also reoptimized and delivered with inclusion of material overrides to equate relative stopping power of the fixture with that of a previously measured result.ResultsPlans exhibit slightly greater dose weight towards AO beams. The optimizer accounted for inclusion of fixture overrides by increasing beam weights to the beam closest to the implant. Film measurements exhibited cold spots directly within the beam path through the fixture in plans with and without overridden materials. Cold spots were somewhat mitigated in plans including overridden materials in the structure set but were not entirely eliminated. Cold spots associated with Am and PFM fixtures were quantified at 17% and 14% for plans without overrides, respectively, and 11% and 9% with using Monte Carlo simulation. Compared with film measurements and Monte Carlo simulation, the treatment planning system underestimates the dose shadowing effect in plans including material overrides.ConclusionsDental fixtures create a dose shadowing effect directly in line with the beam path through the material. This cold spot is partially mitigated by overriding the material to measured relative stopping powers. Due to uncertainties in modeling perturbation through the fixture, the magnitude of the cold spot is underestimated using the institutional TPS when compared to measurement and MC simulation.
Fabrication of custom oral positioning devices in head and neck proton radiotherapy
Lee, Sarah Kay Youny , Bigsby, Arthur, Deisher, A., Mundy, Daniel W. , Muller, Olivia M. , Deisher, Amanda, Mundy, Daniel, Muller, Olivia, Morris, Jonathan M.

Mayo Clinic

Journal of Prosthodontics | March 27, 2023 | Volume: 32 | Issue: 6 | Pages: 546-550

10.1111/jopr.13682 | PMID 36972190 Get It

AbstractWith complex head and neck diseases that closely approximate crucial organs or have advanced spread and cannot be surgically resected, intensity modulated proton beam radiotherapy is favored due to its superior dose targeting through magnetic manipulation of the proton energy. A radiation mask and an oral positioning device immobilize craniofacial, cervical, and oral structures for accurate and reliable radiation delivery. Widely available prefabricated thermoplastic oral positioning devices are manufactured in standardized forms and materials that unpredictably affect the proton beams’ pathways and range. This technique article showcases a workflow that combines analog and digital dental techniques to produce a customized 3D‐printed oral positioning device within 2 appointments.